GnRH agonists and in vitro fertilization
- PMID: 9564657
GnRH agonists and in vitro fertilization
Abstract
GnRH agonists (GnRH-a) were introduced into in vitro fertilization (IVF) superovulation regimens in the late 1980s and have become established as a component of standard regimens in most centers worldwide. Each style of GnRH-a regimen (long, short or ultrashort) is associated with particular advantages and disadvantages. In general the "long protocol" approach tends to be the most widely used. The pros and cons of these different approaches are discussed, as are issues concerned with the management and safety of GnRH-a regimens in IVF.
Similar articles
-
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.Fertil Steril. 2009 Jul;92(1):226-30. doi: 10.1016/j.fertnstert.2008.04.024. Epub 2008 Aug 3. Fertil Steril. 2009. PMID: 18675961
-
Gonadotropin releasing hormone agonists and the induction or augmentation of ovulation.J Reprod Med. 1989 Dec;34(12 Suppl):1034-8. J Reprod Med. 1989. PMID: 2533619
-
GnRH antagonists in ovarian stimulation for IVF.Hum Reprod Update. 2006 Jul-Aug;12(4):333-40. doi: 10.1093/humupd/dml001. Epub 2006 Mar 27. Hum Reprod Update. 2006. PMID: 16567347 Review.
-
[Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].J Gynecol Obstet Biol Reprod (Paris). 2004 Oct;33(6 Pt 2):3S24-6. J Gynecol Obstet Biol Reprod (Paris). 2004. PMID: 15643682 Review. French.
-
[A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].Zhonghua Fu Chan Ke Za Zhi. 2001 Apr;36(4):222-5. Zhonghua Fu Chan Ke Za Zhi. 2001. PMID: 11783366 Clinical Trial. Chinese.
Cited by
-
Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation.Reprod Biol Endocrinol. 2013 Sep 12;11:90. doi: 10.1186/1477-7827-11-90. Reprod Biol Endocrinol. 2013. PMID: 24028076 Free PMC article.
-
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.Cochrane Database Syst Rev. 2015 Nov 9;2015(11):CD006919. doi: 10.1002/14651858.CD006919.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2025 Jan 9;1:CD006919. doi: 10.1002/14651858.CD006919.pub5. PMID: 26558801 Free PMC article. Updated.
-
Recombinant follitropin alfa/lutropin alfa in fertility treatment.Biologics. 2010 Feb 4;4:5-17. Biologics. 2010. PMID: 20161981 Free PMC article.
-
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5. Cochrane Database Syst Rev. 2025. PMID: 39783453
-
Acute Transverse Myelitis Associated with Buserelin Use during IVF.Case Rep Obstet Gynecol. 2013;2013:386765. doi: 10.1155/2013/386765. Epub 2013 Mar 28. Case Rep Obstet Gynecol. 2013. PMID: 23607013 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous